Masahiro Iwamoto

Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors

Takayasu Nagahara, Yukio Yokoyama, Kazue Inamura et al. · Journal of Medicinal Chemistry · 1994 · 178 citations · Full text

Factor X, Medicinal Chemistry, Pharmaceutical Chemistry +15

Increased Levels of Interleukin 33 in Sera and Synovial Fluid from Patients with Active Rheumatoid Arthritis

Yasushi Matsuyama, Hitoaki Okazaki, Hiroyuki Tamemoto et al. · The Journal of Rheumatology · 2009 · 161 citations · Full text

DX-9065a, a New Synthetic, Potent Anticoagulant and Selective Inhibitor for Factor Xa

Tsuyoshi Hara, Asako Yokoyama, Hiroaki Ishihara et al. · Thrombosis and Haemostasis · 1994 · 153 citations

Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.

Hitoaki Okazaki, Daisuke Hirata, Takeshi Kamimura et al. · PubMed · 2002 · 124 citations

Humanized monoclonal anti–interleukin‐6 receptor antibody for treatment of intractable adult‐onset Still's disease

Masahiro Iwamoto, Hiroyuki Nara, Daisuke Hirata et al. · Arthritis & Rheumatism · 2002 · 121 citations

Autoimmune Disease, Immunodeficiencies, Intractable Adult‐onset +7